Gilead is buying Kite Pharma, a cancer-fighting Santa Monica biotech firm, for $11.9 billion – Los Angeles Times
Posted: August 30, 2017 at 9:44 am
Santa Monica biotech company Kite Pharma Inc. is being acquired by industry giant Gilead Sciences Inc. in an $11.9-billion deal that demonstrates the promise of using a persons own immune system to fight cancer.
Foster City-based Gilead said Monday that it would maintain and even expand Kite Pharmas Los Angeles area operations, which include a 100,000-square-foot manufacturing facility in El Segundo.
Dr. Arie Belldegrun, Kite Pharmas founder and chief executive, will help during the merger transition, a Gilead spokeswoman said, but she offered no details on leadership plans beyond that.
The purchase of Kite, which is on the verge of gaining approval for an innovative treatment, expands the cancer-fighting portfolio of Gilead.
The acquisition of Kite establishes Gilead as a leader in cellular therapy and provides a foundation from which to drive continued innovation for people with advanced cancers, Gilead Chief Executive John F. Milligan said in a statement.
Kite Pharma has a cell therapy treatment for non-Hodgkins lymphoma under review by the Food and Drug Administration that uses a patients immune cells to fight cancerous cells. Swiss drugmaker Novartis Corp. also is developing a similar cell therapy treatment for a rare form of leukemia, which is poised to become the first gene therapy to receive FDA approval.
Cell therapy, like many cancer treatments, is expected to be expensive. The costs to patients and providers could cause problems for Gilead, which has come under fire for the high price of its drugs.
Kevin Young, Gileads chief operating officer, would not say Monday what the treatment would cost. But he told analysts on a conference call that I certainly think this innovation will support very healthy reimbursement.
Gilead is to pay $180 in cash for each share of Kite Pharma, a 29% premium over the Friday closing price. Kite Pharma stock leaped 28% to $178.05 on Monday. Gilead shares rose about 1% to $74.69.
Since the start of the year, Kite Pharmas stock price has nearly quadrupled. The shares got a significant boost after a study of the companys gene therapy reported positive results.
The boards of both companies have approved the deal, and its expected to close by the end of the year.
Gilead has developed top-selling treatments for HIV and the liver-destroying hepatitis C virus, but leaders of the biotechnology company told analysts Monday that its push into oncology has been largely nascent so far.
Kite Pharmas research and development, as well as commercialization operations, are to remain in Santa Monica. Manufacturing of Kite Pharmas treatment is to continue at the facility in El Segundo. Kite Pharma has about 600 employees at the two facilities combined, company spokeswoman Christine Cassiano said.
Gilead was impressed with Kite Pharmas team and plans to keep investing in its operations, said Gilead spokeswoman Amy Flood.
The transaction is not about financial synergies or cost savings, she said. This is a growth area, and we anticipate we will increase the number of employees at Kite.
Analysts said it made sense for Gilead to keep and even expand Kite Pharmas Los Angeles-area operations.
That manufacturing in L.A., that marketing team, I think is really, really critical in the process, especially when theyre about to launch in this area, said Tony Butler, an analyst at Guggenheim Securities.
Its important that they keep that together, he said.
Biren Amin, an equity analyst at Jefferies, said Gilead was unlikely to make a change to Kite Pharmas operations with FDA approval of its treatment right around the corner.
If one even thought about transferring it out of El Segundo, I think it would be next to impossible because youd have to have that site up and running for product launch later this year, Amin said.
Kite Pharma was founded in 2009 by Belldegrun, an Israeli-born cancer doctor with decades of experience in immunotherapy. It went public in 2014.
Its cancer treatment, called CAR T, involves reprogramming a patient's disease-fighting T-cells to seek and destroy only abnormal, cancerous lymph cells. Healthy cells are not harmed.
The process involves drawing blood from a patient, refrigerating it and flying it to Kites facilities, where the cells are modified, frozen and then flown back to doctors who reinject them into patients.
In a 2015 interview with the Los Angeles Times, Belldegrun likened the cancer-fighting treatment to the navigation system in an automobile.
"The GPS will lead you to the cancer cell, and not the normal cell, and selectively kill only the cancer cell," Belldegrun said.
In February, Kite Pharma reported that a major study of the gene therapy process found that more than a third of very sick lymphoma patients showed no signs of the disease six months after a single treatment. And 82% of patients had their cancer shrink at least by half at some point after the treatment, the study found.
CAR T has the potential to become one of the most powerful anti-cancer agents for hematologic cancers, Belldegrun said in a statement Monday. With Gileads expertise and support, we hope to fulfill that potential by rapidly accelerating our robust pipeline and next-generation research and manufacturing technologies.
Gilead was criticized two years ago for high prices for its hepatitis C drugs, including one that began at $1,000 per pill. The drugs were developed by biotech firm Pharmasset Inc., which Gilead acquired in 2011.
A bipartisan Senate Finance Committee report in 2015 said that Gilead put profits before patients in pricing the drug. Also, AIDS activists have complained about the prices of Gileads HIV medications.
The CAR T treatment could be expensive as well because of the complexities of the therapy. Novartis treatment very likely will hit the market first so Gilead will have that price to work from, said Alan Carr, an analyst at Needham & Co.
There are a lot of oncology drugs right now that are expensive. Theres a lot of controversy around that, he said. Im not sure that Gilead is particularly susceptible to that.
The Associated Press was used in compiling this report.
Twitter: @JimPuzzanghera
UPDATES:
3:15 p.m.: This article was updated with information about Kite Pharma founder Dr. Arie Belldegrun.
1:25 p.m.: This article was updated with the closing stock prices for Kite Pharma and Gilead Sciences.
1:05 p.m.: This article was updated with analyst comment and additional details about drug pricing.
8:30 a.m.: This article was updated with details about Kite Pharmas workforce and current stock prices.
7 a.m.: This article was updated with additional detail and the opening stock prices of Kite Pharma and Gilead.
6:45 a.m.: This article was updated throughout with staff reporting.
This article was originally published at 5:25 a.m.
Read this article:
Gilead is buying Kite Pharma, a cancer-fighting Santa Monica biotech firm, for $11.9 billion - Los Angeles Times
- Gene Therapy | Doctor | Patient.co.uk [Last Updated On: May 23rd, 2015] [Originally Added On: May 23rd, 2015]
- Gene Therapy | Doctor | Patient [Last Updated On: June 9th, 2015] [Originally Added On: June 9th, 2015]
- Dr Rajiv Desai Blog Archive GENE THERAPY [Last Updated On: August 23rd, 2015] [Originally Added On: August 23rd, 2015]
- Local Doctor Leads Study Of Gene Therapy Treatment For ... [Last Updated On: March 19th, 2016] [Originally Added On: March 19th, 2016]
- Breast Cancer Risk Factors: Genetics [Last Updated On: August 24th, 2016] [Originally Added On: August 24th, 2016]
- Worlds Leading Biomarkers Congress | CPD Points ... [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- Why the super-rich are ploughing billions into the booming 'immortality industry' - Evening Standard [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- What to Know About Charlie Gard, the Terminally Ill Baby Trump Wants to Help - TIME [Last Updated On: July 4th, 2017] [Originally Added On: July 4th, 2017]
- Cancer treatment is swiftly moving toward individualized molecular and genetic tools that Sparrow Cancer Center's ... - City Pulse [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Tumor gene testing urged to tell if drug targets your cancer - ABC News [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Tumor gene testing urged to tell if drug targets your cancer | KRQE ... - KRQE News 13 [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Tumor gene testing urged to tell if drug targets your cancer - The ... - The Mainichi [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Charlie Gard: Medical experts weigh in on case of terminally-ill baby - The Independent [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- High-tech solutions top the list in the fight against eye disease - Engadget [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- 'Prehab' therapy helps cancer patients prepare for treatment - KTBS [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- Baby Charlie remains on life support as parents fight doctors for experimental treatment - CBC.ca [Last Updated On: July 13th, 2017] [Originally Added On: July 13th, 2017]
- Novel cancer treatment wins endorsement of FDA advisers - Washington Post [Last Updated On: July 13th, 2017] [Originally Added On: July 13th, 2017]
- Ocean Springs parents fight to save 3-year-old daughter from fatal genetic condition - WGNO [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- US doctor who wanted to treat Charlie Gard had 'financial interest' says Great Ormond Street - Metro [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- New cancer therapy in clinical trial at Nebraska Medical Center has ... - Omaha World-Herald [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]
- Scientists successfully doctor human embroyo - Examiner Enterprise [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- WBZ-TV Riders Take On Pan-Mass Challenge - CBS Boston / WBZ [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Gene editing breakthrough: Perspective from a geneticist and a pastor - WTSP 10 News [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Indian-origin doctor helps gene editing of human embryos - Times of India [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- New Gene Therapy for Vision Loss Proven Safe in Humans ... [Last Updated On: August 8th, 2017] [Originally Added On: August 8th, 2017]
- Springfield Mom Works to Raise Awareness after Son Diagnosed with Rare Genetic Disorder - KSMU Radio [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- Cancer's Newest Miracle Cure - TIME [Last Updated On: August 10th, 2017] [Originally Added On: August 10th, 2017]
- Families with kids with Jordan's Syndrome meet for study to learn more about rare gene mutation - FOX 5 DC [Last Updated On: August 11th, 2017] [Originally Added On: August 11th, 2017]
- Springfield Mom Works to Raise Awareness after Son Diagnosed with Rare Genetic Disorder - KRCU [Last Updated On: August 11th, 2017] [Originally Added On: August 11th, 2017]
- Exclusive interview with Discovery's First in Human sickle cell ... - Monsters and Critics.com [Last Updated On: August 18th, 2017] [Originally Added On: August 18th, 2017]
- DHK - Representative Chris Walsh, 66, non-Hodgkin lymphoma (a white blood cell cancer), Framingham, with Dr ... - WEEI.com [Last Updated On: August 21st, 2017] [Originally Added On: August 21st, 2017]
- Life Lessons: Next generation testing - WFMZ Allentown [Last Updated On: August 21st, 2017] [Originally Added On: August 21st, 2017]
- Potential therapy for eye condition - WTAJ [Last Updated On: August 21st, 2017] [Originally Added On: August 21st, 2017]
- New 3D-drug screening aims to ease economic burden of rare muscle diseases - Medical Xpress [Last Updated On: August 22nd, 2017] [Originally Added On: August 22nd, 2017]
- Doctor on new cancer treatment: 'genetically engineered, tumor-killing factory' - The Business Journal [Last Updated On: August 23rd, 2017] [Originally Added On: August 23rd, 2017]
- Baltimore 5K Aims to Raise Awareness about Sickle Cell Disease - Afro American [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- Stanford Center Hopes to Take Stem Cell and Gene Therapies to a New Level - Sickle Cell Anemia News [Last Updated On: August 25th, 2017] [Originally Added On: August 25th, 2017]
- Man describes new FDA-approved gene therapy for leukemia that changed his life - fox4kc.com [Last Updated On: September 1st, 2017] [Originally Added On: September 1st, 2017]
- First gene therapy to treat cancer gets FDA approval; UM only Michigan hospital to use it - Detroit Free Press [Last Updated On: September 1st, 2017] [Originally Added On: September 1st, 2017]
- Why the federal government urgently needs to fund more cancer research - Los Angeles Times [Last Updated On: September 6th, 2017] [Originally Added On: September 6th, 2017]
- New 'hit-and-run' gene editing tool temporarily rewrites genetics to treat cancer and HIV - GeekWire [Last Updated On: September 6th, 2017] [Originally Added On: September 6th, 2017]
- UTSA Presidential Lecture featuring Leonard Pinchuk - UTSA Today [Last Updated On: September 6th, 2017] [Originally Added On: September 6th, 2017]
- South Bend man a 'walking miracle' after cancer treatment breakthrough - South Bend Tribune [Last Updated On: September 6th, 2017] [Originally Added On: September 6th, 2017]
- Gene therapy - Doctor.ndtv.com [Last Updated On: May 18th, 2018] [Originally Added On: May 18th, 2018]
- what is gene therapy? - Bluebird Bio [Last Updated On: May 24th, 2018] [Originally Added On: May 24th, 2018]
- Oncotype DX: Genomic Test to Inform Breast Cancer Treatment [Last Updated On: September 29th, 2018] [Originally Added On: September 29th, 2018]
- Gene Therapy: The Future of Vision Treatment [Last Updated On: February 21st, 2019] [Originally Added On: February 21st, 2019]
- Gene Therapy Questions | FAQs - Dana-Farber/Boston ... [Last Updated On: April 22nd, 2019] [Originally Added On: April 22nd, 2019]
- Gene therapy might be a cure for "bubble boy disease ... [Last Updated On: April 24th, 2019] [Originally Added On: April 24th, 2019]
- Xconomy: SMA Moment: Will Gene Therapy Shift Treatment ... [Last Updated On: May 2nd, 2019] [Originally Added On: May 2nd, 2019]
- A Study to Evaluate the Efficacy and Safety of Factor IX ... [Last Updated On: May 26th, 2019] [Originally Added On: May 26th, 2019]
- Targeted Therapy | Treating Mesothelioma - Mesothelioma Hub [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Why the focus of autism research is shifting away from searching for a 'cure' - NBCNews.com [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Here's What Happened to Dr. Sharpe on 'New Amsterdam' Details! - Distractify [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Gene therapy drug priced at $2 million saves North Carolina babys life - WTKR News 3 [Last Updated On: September 26th, 2019] [Originally Added On: September 26th, 2019]
- Pollard and Norris in the race for Pos. 2 of the Public Hospital District 4 - Snoqualmie Valley Record [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Three to be honored as Distinguished Clay High School Alumni - Press Publications Inc. [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Nearly Half of Poland's SMA Patients on Track to Get Spinraza, Experts Say - SMA News Today [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Genentech to Present Results of First Prospective Trial Using Blood-based Next Generation Sequencing Which Successfully Identifies People for... [Last Updated On: October 2nd, 2019] [Originally Added On: October 2nd, 2019]
- Beyonc's father Mathew Knowles has breast cancer: Here's what you need to know about the disease in men - Yahoo Lifestyle [Last Updated On: October 4th, 2019] [Originally Added On: October 4th, 2019]
- Study Measures Prognosis for Breast Cancer Patients with High 21-gene Recurrence Score Receiving Adjuvant Chemotherapy Plus Endocrine Therapy -... [Last Updated On: October 4th, 2019] [Originally Added On: October 4th, 2019]
- Beyoncs father diagnosed with breast cancer - Houston Chronicle [Last Updated On: October 4th, 2019] [Originally Added On: October 4th, 2019]
- What one doctor thinks about drug shortages and how to solve them - STAT [Last Updated On: October 4th, 2019] [Originally Added On: October 4th, 2019]
- The facts about breast cancer awareness | News - The Albany Herald [Last Updated On: October 8th, 2019] [Originally Added On: October 8th, 2019]
- Metastatic Breast Cancer: What You Should Know - University of Michigan Health System News [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- John Geyman on the Failure of Obamacare the Medical Industrial Complex and the Single Payer Solution - Corporate Crime Reporter [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- Quebec to cover revolutionary cancer treatment for types of leukemia and non-Hodgkins lymphoma - CTV News [Last Updated On: October 11th, 2019] [Originally Added On: October 11th, 2019]
- Deepak Chopra Has Never Been Sick - The New Yorker [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Daughter drew inspiration from mom in battle with breast cancer, stresses early detection - Gainesville Daily Register [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Cleft palate or lip is one of the most common birth defects worldwide, but do you know what it is? - ABC News [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Pearland family fighting to get $2.1 million drug for toddler with rare genetic disease - KHOU.com [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Gene-Therapy Treatment Could Help People with Macular Degeneration - Healthline [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- A Netflix Series Explores the Brave New World of Crispr - WIRED [Last Updated On: October 18th, 2019] [Originally Added On: October 18th, 2019]
- Save your child from paediatric cancer: Know what to look out for - TheHealthSite [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- The 'Magic' Behind Every Successful Blockbuster Drug - DailyWealth [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- $2.1 million drug approved for Pearland toddler with rare genetic disease - KHOU.com [Last Updated On: October 19th, 2019] [Originally Added On: October 19th, 2019]
- Genentech's Tecentriq in Combination With Avastin Increased Overall Survival and Progression-free Survival in People With Unresectable Hepatocellular... [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Why Are More Black Women Dying From the Most Common Reproductive Cancer? - Mother Jones [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- 5 Biotech and Pharmaceutical Innovation Trends in 2019 - BioSpace [Last Updated On: October 23rd, 2019] [Originally Added On: October 23rd, 2019]
- Breast Cancer in Men | Outlook - Big Bear Grizzly [Last Updated On: October 24th, 2019] [Originally Added On: October 24th, 2019]